pMV306hsp+LuxG13 Citations (17)

Originally described in: Optimisation of bioluminescent reporters for use with mycobacteria.
Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, Wiles S PLoS One. 2010 May 24;5(5):e10777. PubMed Journal

---

Articles Citing pMV306hsp+LuxG13

Articles
Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents. Sandhaus S, Annamalai T, Welmaker G, Houghten RA, Paz C, Garcia PK, Andres A, Narula G, Rodrigues Felix C, Geden S, Netherton M, Gupta R, Rohde KH, Giulianotti MA, Tse-Dinh YC. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4028-36. doi: 10.1128/AAC.00288-16. Print 2016 Jul. PubMed
Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery. Naran K, Moosa A, Barry CE 3rd, Boshoff HI, Mizrahi V, Warner DF. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6748-6757. doi: 10.1128/AAC.01178-16. Print 2016 Nov. PubMed
Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products. Rodrigues Felix C, Gupta R, Geden S, Roberts J, Winder P, Pomponi SA, Diaz MC, Reed JK, Wright AE, Rohde KH. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00743-17. doi: 10.1128/AAC.00743-17. Print 2017 Aug. PubMed
Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish. Myllymaki H, Niskanen M, Luukinen H, Parikka M, Ramet M. Dis Model Mech. 2018 Mar 13;11(3). pii: 11/3/dmm033175. doi: 10.1242/dmm.033175. PubMed
Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape. Baranowski C, Welsh MA, Sham LT, Eskandarian HA, Lim HC, Kieser KJ, Wagner JC, McKinney JD, Fantner GE, Ioerger TR, Walker S, Bernhardt TG, Rubin EJ, Rego EH. Elife. 2018 Oct 16;7. pii: 37516. doi: 10.7554/eLife.37516. PubMed
An explant technique for high-resolution imaging and manipulation of mycobacterial granulomas. Cronan MR, Matty MA, Rosenberg AF, Blanc L, Pyle CJ, Espenschied ST, Rawls JF, Dartois V, Tobin DM. Nat Methods. 2018 Dec;15(12):1098-1107. doi: 10.1038/s41592-018-0215-8. Epub 2018 Nov 30. PubMed
Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent. Hanh BTB, Park JW, Kim TH, Kim JS, Yang CS, Jang K, Cui J, Oh DC, Jang J. Molecules. 2020 Mar 31;25(7). pii: molecules25071597. doi: 10.3390/molecules25071597. PubMed
Antimicrobial photodynamic therapy fighting polymicrobial infections - a journey from in vitro to in vivo. Karner L, Drechsler S, Metzger M, Hacobian A, Schadl B, Slezak P, Grillari J, Dungel P. Photochem Photobiol Sci. 2020 Oct 1;19(10):1332-1343. doi: 10.1039/d0pp00108b. Epub 2020 Sep 30. PubMed
Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance, and Persistence. Savijoki K, Myllymaki H, Luukinen H, Paulamaki L, Vanha-Aho LM, Svorjova A, Miettinen I, Fallarero A, Ihalainen TO, Yli-Kauhaluoma J, Nyman TA, Parikka M. mSystems. 2021 Jun 29;6(3):e0050021. doi: 10.1128/mSystems.00500-21. Epub 2021 Jun 22. PubMed
Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis. van Schie L, Borgers K, Michielsen G, Plets E, Vuylsteke M, Tiels P, Festjens N, Callewaert N. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0065921. doi: 10.1128/AAC.00659-21. Epub 2021 Jul 19. PubMed
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis. Larkins-Ford J, Greenstein T, Van N, Degefu YN, Olson MC, Sokolov A, Aldridge BB. Cell Syst. 2021 Nov 17;12(11):1046-1063.e7. doi: 10.1016/j.cels.2021.08.004. Epub 2021 Aug 31. PubMed
Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus. Lee DG, Hwang YH, Park EJ, Kim JH, Ryoo SW. Int J Mol Sci. 2021 Oct 13;22(20). pii: ijms222011029. doi: 10.3390/ijms222011029. PubMed
Investigate Natural Product Indolmycin and the Synthetically Improved Analogue Toward Antimycobacterial Agents. Yang Y, Xu Y, Yue Y, Wang H, Cui Y, Pan M, Zhang X, Zhang L, Li H, Xu M, Tang Y, Chen S. ACS Chem Biol. 2022 Jan 21;17(1):39-53. doi: 10.1021/acschembio.1c00394. Epub 2021 Dec 15. PubMed
CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A. Babunovic GH, DeJesus MA, Bosch B, Chase MR, Barbier T, Dickey AK, Bryson BD, Rock JM, Fortune SM. mBio. 2022 Jan 18:e0368321. doi: 10.1128/mbio.03683-21. PubMed
TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages. Dabla A, Liang YC, Rajabalee N, Irwin C, Moonen CGJ, Willis JV, Berton S, Sun J. mBio. 2022 Aug 30;13(4):e0145622. doi: 10.1128/mbio.01456-22. Epub 2022 Aug 4. PubMed
Mycobacterium abscessus DosRS two-component system controls a species-specific regulon required for adaptation to hypoxia. Simcox BS, Tomlinson BR, Shaw LN, Rohde KH. Front Cell Infect Microbiol. 2023 Mar 9;13:1144210. doi: 10.3389/fcimb.2023.1144210. eCollection 2023. PubMed
Clinically relevant mutations in the PhoR sensor kinase of host-adapted Mycobacterium abscessus isolates impact response to acidic pH and virulence. Belardinelli JM, Arora D, Avanzi C, Wheat WH, Bryant JM, Spencer JS, Blundell TL, Parkhill J, Floto RA, Jackson M. Microbiol Spectr. 2023 Dec 12;11(6):e0158823. doi: 10.1128/spectrum.01588-23. Epub 2023 Oct 24. PubMed

If you have published an article using this material, please email us at to have your article added to this page.